152 related articles for article (PubMed ID: 8813469)
1. The ultimate biochemical diagnosis of neuroendocrine gastro-enteropancreatic tumours.
Faiss S; Scherübl H; Riecken EO; Wiedenmann B
Digestion; 1996; 57 Suppl 1():48-9. PubMed ID: 8813469
[TBL] [Abstract][Full Text] [Related]
2. The ultimate biochemical diagnosis of gastro-enteropancreatic tumours.
Oberg K
Digestion; 1996; 57 Suppl 1():45-7. PubMed ID: 8813468
[TBL] [Abstract][Full Text] [Related]
3. GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers.
Verbeek WH; Korse CM; Tesselaar ME
Eur J Endocrinol; 2016 Jan; 174(1):R1-7. PubMed ID: 26162406
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Plöckinger U; Wiedenmann B
Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
[TBL] [Abstract][Full Text] [Related]
5. A comparison of imaging techniques for the localisation of gastro-enteropancreatic neuroendocrine tumours.
Chayvialle JA
Digestion; 1996; 57 Suppl 1():54-6. PubMed ID: 8813471
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X; ;
Clin Transl Oncol; 2014 Mar; 16(3):243-56. PubMed ID: 23749327
[TBL] [Abstract][Full Text] [Related]
7. Biological aspects of neuroendocrine gastro-enteropancreatic tumours.
Oberg K
Digestion; 1996; 57 Suppl 1():42-4. PubMed ID: 8813467
[TBL] [Abstract][Full Text] [Related]
8. Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.
Maxwell JE; O'Dorisio TM; Howe JR
Surg Oncol Clin N Am; 2016 Jan; 25(1):171-94. PubMed ID: 26610781
[TBL] [Abstract][Full Text] [Related]
9. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
10. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G; La Rosa S
Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
[TBL] [Abstract][Full Text] [Related]
11. Role of biomarker tests for diagnosis of neuroendocrine tumours.
Hofland J; Zandee WT; de Herder WW
Nat Rev Endocrinol; 2018 Nov; 14(11):656-669. PubMed ID: 30158549
[TBL] [Abstract][Full Text] [Related]
12. Intervention in gastro-enteropancreatic neuroendocrine tumours.
Baudin E; Planchard D; Scoazec JY; Guigay J; Dromain C; Hadoux J; Debaere T; Elias D; Ducreux M
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):855-65. PubMed ID: 23582924
[TBL] [Abstract][Full Text] [Related]
13. Workup of Gastroenteropancreatic Neuroendocrine Tumors.
Dillon JS
Surg Oncol Clin N Am; 2020 Apr; 29(2):165-183. PubMed ID: 32151354
[TBL] [Abstract][Full Text] [Related]
14. Duodeno-pancreatic neuroendocrine tumours.
Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
[TBL] [Abstract][Full Text] [Related]
15. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
[TBL] [Abstract][Full Text] [Related]
16. [Management of patients with non-functioning gastroentero-pancreatic neuroendocrine tumours].
Guarnieri A; Tirone A; Pallucca E; Testa M; Piccolomini A; Vuolo G; Savelli V; Di Cosmo L; Verre L; Carli AF
Chir Ital; 2006; 58(3):389-96. PubMed ID: 16845879
[TBL] [Abstract][Full Text] [Related]
17. Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetes.
Herold Z; Uhlyarik A; Herold M; Nagy P; Huszty GD; Rosta K; Doleschall M; Somogyi A
Endokrynol Pol; 2020; 71(5):483-484. PubMed ID: 32856287
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
19. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
[TBL] [Abstract][Full Text] [Related]
20. New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.
Wiedenmann B; Ahnert-Hilger G; Kvols LK; Riecken EO
Ann N Y Acad Sci; 1994 Sep; 733():515-25. PubMed ID: 7978902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
